JENIFER RAYMOND: Open Payments
NPI 1356126577 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 53 payments from 10 companies in 2025. Trend: 2023 $170 · 2024 $1,524 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $206 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Alkermes, Inc. | 1 | $26 |
| Almatica Pharma LLC | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, FANAPT, TRINTELLIX, REXULTI, INGREZZA, ARISTADA, LOREEV XR.
Industry payments across FL — which companies pay providers there.
